Americans and citizens of other countries may be rejecting further COVID mRNA gene level treatments (deceptively equated by authorities to traditional vaccines) at levels between 70 and 80 percent.
Tag: COVID-19
Post
TOP CDC JOURNAL’S TAKE ON MASK USE CHALLENGED
The authors of a recent article accepted in a top medical journal took issue with claims that the Centers for Disease Control and Prevention made about mask use and their effectiveness in preventing the spread of COVID-19.
Post
VITAMIN D FOR COVID-19, DIABETES AND HEART HEALTH
Vitamin D levels affect the severity of COVID-19 infection and maintaining optimal levels may reduce symptoms and related long-term complications
Post
IN THE WAR OVER TAKING COVID JABS, THE NAYS NOW PREVAIL BY A HUGE MARGIN
Most Americans—even the ones who previously scrambled, or submitted out of pressure, to take a COVID jab—are now saying no to the shots.
Post
‘TURBO CANCERS’ LINKED TO COVID JABS
Oncologists are reporting an alarming rise in post-jab “turbo cancers,” a term coined to describe incredibly rapid-growing cancers in people who have received one or more COVID jabs
Post
CDC ACCUSED OF REPEATEDLY MISREPRESENTING MASK RESEARCH EVEN WHEN MASKED GROUP HAD HIGHER COVID INFECTION RATE
An independent review on the effectiveness of masks during the COVID-19 accused the Centers for Disease Control and Prevention of grossly exaggerating the data to support wearing masks to prevent the spread of the virus.
Post
HAS THE POST-COVID TRAVEL BOOM PEAKED?
JetBlue Airways reported a downturn in U.S. domestic travel in August, while low-fare Spirit Airlines has issued a profit warning and has resorted to “deep discounting” to spur ticket sales.
Post
RETAILERS IN U.S. REPORT ‘UNPRECEDENTED LEVELS’ OF THEFT
The National Retail Federation released a survey last Tuesday that stores across the U.S. lost an “unprecedented” $112.1 billion to theft in 2022.
Post
MERCK’S $6B COVID-19 ANTIVIRAL DRUG MAY CONTRIBUTE TO VIRUS’S MUTATION, SCIENTISTS SAY
Molnupiravir, Merck’s COVID-19 antiviral drug that earned the company $6 billion in sales from 2021 to 2022, may be contributing to the disease’s mutation since the virus can survive the treatment, scientists said.
Post
FDA UPDATES WARNING LABEL FOR OZEMPIC DUE TO LIFE-THREATENING INTESTINAL BLOCKAGE RISK
The U.S. Food and Drug Administration announced last week that it will update the warning label on Ozempic—the diabetes drug popular for weight loss—due to the risk of intestinal blockage while on the drug.